At 5.9% CAGR, the Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market is projected to be worth US$ 201.37 Million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market was valued at US$ 143.04 million in 2022 and is expected to reach US$ 201.37 million by 2028, registering an annual growth rate of 5.9% from 2022 to 2028. Rising investments in pharma sector and new product launches & FDA approvals for noninvasive tests are the critical factors attributed to the market expansion.

The encouraging response of non-invasive tests in the global market has further propelled market research and development activities. The key players in the global Helicobacter pylori non-invasive test market are Meridian Bioscience, DiaSporin, Exalenz Bioscience, Biomerica, Alere, Sekisui Diagnostics, and others. The pharmaceutical giants have also adopted strategic alliances such as collaboration, partnerships, or acquisitions to maintain a strategic edge in the global market.

In 2020, Meridian Bioscience entered a definitive agreement to acquire Exalenz for about US$ 49 million. Under the terms of the agreement, Meridian will be adding Exalenz's flagship BreathID® Breath Test Systems, a urea breath test platform for the detection of H. pylori.

In 2018, DiaSorin entered into a strategic collaboration with Meridian Bioscience to commercialize DiaSorin's FDA-cleared H. pylori stool antigen test to detect H. pylori for use on its automated LIAISON platform under the Meridian brand name.   

On the contrary, very low diagnosis rate hurdles the growth of Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market.

• Based on test type, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market in 2022 with a share of 44.9%, amassing US$ 9 64.23 million. It is projected to garner US$ 92.41 million by 2028 to expand at 6.3% CAGR during 2022–2028.
• Based on test method, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022 with a share of 75.4%, amassing US$ 107.92 million. It is projected to garner US$ 153.49 million by 2028 to expand at 6.0% CAGR during 2022–2028.
• Based on end user, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022 with a share of 58.7%, amassing US$ 83.90 million. It is projected to garner US$ 119.96 million by 2028 to expand at 6.1% CAGR during 2022–2028.

Our regional analysis states that China captured 30.7% market share in 2022. It was assessed at US$ 43.88 million in 2022 and is likely to hit US$ 62.73 million by 2028, exhibiting a CAGR of 6.1% during the forecast period.

Key players dominating the Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market are Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc.

Below are mentioned a few key market developments by major players:

• In Dec 2021, Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.

• In April 2020, Meridian Bioscience, Inc. has completed the acquisition of Exalenz Bioscience Ltd., the Modiin, Israel-based provider of the BreathID Breath Test Systems, a urea breath test platform for the detection of Helicobacter pylori.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com